Evaluating the utility of synthetic COVID-19 case data
Related Experiment Video
Updated: Nov 13, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Khaled El Emam1,2,3, Lucy Mosquera3, Elizabeth Jonker2
1School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Background:
Concerns about patient privacy have limited access to COVID-19 datasets. Data synthesis is one approach for making such data broadly available to the research community in a privacy protective manner.
Objectives:
Evaluate the utility of synthetic data by comparing analysis results between real and synthetic data.
Methods:
A gradient boosted classification tree was built to predict death using Ontario's 90 514 COVID-19 case records linked with community comorbidity, demographic, and socioeconomic characteristics. Model accuracy and relationships were evaluated, as well as privacy risks. The same model was developed on a synthesized dataset and compared to one from the original data.
Results:
The AUROC and AUPRC for the real data model were 0.945 [95% confidence interval (CI), 0.941-0.948] and 0.34 (95% CI, 0.313-0.368), respectively. The synthetic data model had AUROC and AUPRC of 0.94 (95% CI, 0.936-0.944) and 0.313 (95% CI, 0.286-0.342) with confidence interval overlap of 45.05% and 52.02% when compared with the real data. The most important predictors of death for the real and synthetic models were in descending order: age, days since January 1, 2020, type of exposure, and gender. The functional relationships were similar between the two data sets. Attribute disclosure risks were 0.0585, and membership disclosure risk was low.
Conclusions:
This synthetic dataset could be used as a proxy for the real dataset.
Related Concept Videos
Steps in Outbreak Investigation
Statistical Software for Data Analysis and Clinical Trials
Statistical Methods for Analyzing Epidemiological Data

